| Autor: |
Deng J; University of Pennsylvania, School of Nursing, Biobehavioral Health Sciences, Philadelphia, PA, USA., Lukens JN; University of Pennsylvania, Department of Radiation Oncology, Philadelphia, PA, USA., Zhu J; University of Pennsylvania, School of Nursing, Biobehavioral Health Sciences, Philadelphia, PA, USA., Cohn JC; Good Shepherd Penn Partners, Philadelphia, PA, USA., Andersen LP; University of Pennsylvania, School of Nursing, Biobehavioral Health Sciences, Philadelphia, PA, USA., Spinelli BA; Thomas Jefferson University, Jefferson College of Rehabilitation Sciences, Department of Physical Therapy, Philadelphia, PA, USA., Quinn RJ; University of Pennsylvania, School of Nursing, Biobehavioral Health Sciences, Philadelphia, PA, USA., Chittams J; University of Pennsylvania, School of Nursing, Biobehavioral Health Sciences, Philadelphia, PA, USA., McMenamin E; University of Pennsylvania, Department of Radiation Oncology, Philadelphia, PA, USA., Lin A; University of Pennsylvania, Department of Radiation Oncology, Philadelphia, PA, USA. |
| Abstrakt: |
Purpose: Lymphedema is a common late effect of head and neck cancer treatment that causes various symptoms, functional impairment, and poor quality of life. We completed a pilot, prospective, single-arm clinical trial to determine the feasibility and potential efficacy of the use of photobiomodulation (PBM) therapy for head and neck lymphedema. In this study, we report patients' perceived treatment experience of PBM therapy and provide suggestions to better understand head and neck cancer survivors' experience of PBM therapy. Methods: Head and neck cancer patients who underwent PBM therapy completed face-to-face semi-structured interviews. Interviews were audio-recorded and then transcribed verbatim. Qualitative content analysis was used to analyze the transcriptions from the interviews. Results: Among 12 participants who consented for the study, 11 (91.7%) completed the PBM therapy. Participants described positive experiences and unique benefits about the PBM therapy, for example, decreased swelling, reduced tightness, increased range of motion, increased saliva production, and improved ability to swallow. Some participants ( n = 5, 45.5%) delineated challenges related to traffic, travel time, and distance from study location. Many participants proposed suggestions for future research on PBM therapy, for example, research on internal edema and its relationship with swallowing, and indicated patients with severe lymphedema and fibrosis may be more likely to benefit. Conclusions: Findings from this study suggested the potential benefits of PBM therapy in treatment of chronic head and neck lymphedema. Rigorously designed clinical trials are needed to evaluate the effect of PBM therapy for head and neck cancer-related lymphedema. Trial Registration Number and Date of Registration: ClinicalTrials.gov Identifier: NCT03738332; date of registration: November 13, 2018. |
